Cerity Partners LLC Has $10.01 Million Stake in Omega Healthcare Investors, Inc. $OHI

Cerity Partners LLC grew its holdings in Omega Healthcare Investors, Inc. (NYSE:OHI) by 8.4% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 273,229 shares of the real estate investment trust’s stock after acquiring an additional 21,192 shares during the period. Cerity Partners LLC owned 0.09% of Omega Healthcare Investors worth $10,014,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in OHI. Caitong International Asset Management Co. Ltd bought a new position in shares of Omega Healthcare Investors in the second quarter valued at approximately $26,000. CENTRAL TRUST Co lifted its position in shares of Omega Healthcare Investors by 1,654.4% in the 2nd quarter. CENTRAL TRUST Co now owns 1,000 shares of the real estate investment trust’s stock worth $37,000 after acquiring an additional 943 shares during the period. Cullen Frost Bankers Inc. bought a new position in Omega Healthcare Investors in the second quarter worth $41,000. Bayforest Capital Ltd boosted its position in shares of Omega Healthcare Investors by 395.2% during the 2nd quarter. Bayforest Capital Ltd now owns 1,129 shares of the real estate investment trust’s stock valued at $41,000 after acquiring an additional 901 shares in the last quarter. Finally, Elevation Point Wealth Partners LLC bought a new stake in shares of Omega Healthcare Investors in the 2nd quarter valued at approximately $63,000. Institutional investors and hedge funds own 65.25% of the company’s stock.

Omega Healthcare Investors Trading Down 1.6%

OHI opened at $44.50 on Thursday. Omega Healthcare Investors, Inc. has a 1-year low of $35.04 and a 1-year high of $46.36. The stock has a market capitalization of $13.15 billion, a PE ratio of 24.86, a PEG ratio of 2.02 and a beta of 0.56. The company has a current ratio of 7.11, a quick ratio of 7.11 and a debt-to-equity ratio of 0.95. The firm has a 50-day moving average price of $42.83 and a two-hundred day moving average price of $40.58.

Omega Healthcare Investors (NYSE:OHI) last announced its earnings results on Thursday, October 30th. The real estate investment trust reported $0.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.77 by $0.02. The company had revenue of $311.59 million for the quarter, compared to analyst estimates of $262.48 million. Omega Healthcare Investors had a net margin of 46.83% and a return on equity of 10.72%. Omega Healthcare Investors’s quarterly revenue was up 14.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.71 earnings per share. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. As a group, equities analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, November 17th. Shareholders of record on Monday, November 3rd were given a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a yield of 6.0%. The ex-dividend date was Monday, November 3rd. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 149.72%.

Analyst Ratings Changes

OHI has been the topic of a number of analyst reports. Mizuho upped their price target on Omega Healthcare Investors from $37.00 to $40.00 and gave the company a “neutral” rating in a research report on Thursday, September 11th. Scotiabank boosted their target price on shares of Omega Healthcare Investors from $42.00 to $45.00 and gave the company a “sector perform” rating in a research note on Thursday, November 13th. Truist Financial upped their target price on shares of Omega Healthcare Investors from $44.00 to $46.00 and gave the stock a “hold” rating in a report on Monday, December 1st. Wells Fargo & Company lifted their price target on shares of Omega Healthcare Investors from $45.00 to $48.00 and gave the company an “overweight” rating in a report on Tuesday, November 25th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of Omega Healthcare Investors in a research report on Wednesday, October 8th. Six analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $46.63.

Insider Buying and Selling at Omega Healthcare Investors

In other news, CEO C Taylor Pickett acquired 20,000 shares of the company’s stock in a transaction on Wednesday, November 5th. The stock was purchased at an average cost of $43.14 per share, with a total value of $862,800.00. Following the acquisition, the chief executive officer owned 20,000 shares of the company’s stock, valued at $862,800. This trade represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CIO Vikas Gupta bought 11,500 shares of the business’s stock in a transaction on Thursday, November 6th. The shares were acquired at an average price of $42.97 per share, for a total transaction of $494,155.00. Following the completion of the transaction, the executive owned 13,773 shares in the company, valued at approximately $591,825.81. This trade represents a 505.94% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 1.50% of the stock is currently owned by company insiders.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.